Diet is a risk factor in cisplatin ototoxicity.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Hearing Research

• Publication date

  1995-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0378-5955(95)00097-NPMID 8576002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cisplatin-induced ototoxicity: Audiometric findings and experimental cochlear pathology

  2004cited by this paper
• Absence of relation between nutritional parameters and renal function in non-seminomatous testicular cancer patients

  2004cited by this paper
• Glutathione protection against gentamicin ototoxicity depends on nutritional status.

  1995cited by this paper
• Low-dose glutathione administration in the prevention of cisplatin-induced peripheral neuropathy in rats.

  1994cited by this paper
• Cisplatin nephrotoxicity: decreases in mitochondrial protein sulphydryl concentration and calcium uptake by mitochondria from rat renal cortical slices.

  1994cited by this paper
• Risk factors for ototoxicity due to cisplatin.

  1994cited by this paper
• Glutathione biosynthesis in the postimplantation rat conceptus in vitro.

  1993cited by this paper
• Varied protein intake alters glutathione metabolism in rats.

  1992cited by this paper
• Degeneration of the organ of Corti following intravenous administration of cisplatin.

  1991cited by this paper
• Scar formation after drug-induced cochlear insult.

  1991cited by this paper
• The deleterious effect of buthionine sulfoximine, a glutathione-depleting agent, on the cisplatin toxicity in mice.

  1990cited by this paper
• Interaction of cisplatin and noise on the peripheral auditory system.

  1990cited by this paper
• Glutathione measurement by high-performance liquid chromatography separation and fluorometric detection of the glutathione-orthophthalaldehyde adduct.

  1989cited by this paper
• Molecular basis of cisplatin resistance in human carcinomas: model systems and patients.

  1989cited by this paper
• Cisplatin ototoxicity in guinea pigs with special reference to toxic effects in the stria vascularis

  1988cited by this paper
• High Frequency Audiometry in Prospective Clinical Research of Ototoxicity Due to Platinum Derivatives

  1988cited by this paper
• Ototoxicity of cisplatin in gynaecological cancer patients.

  1988cited by this paper
• Serial determination of platinum, protein content and free sulfhydryl levels in plasma of patients treated with cisplatin or carboplatin.

  1988cited by this paper
• Nutritional status, glutathione levels, and ototoxicity of loop diuretics and aminoglycoside antibiotics.

  1987cited by this paper
• Clinical features of cisplatin vestibulotoxicity and hearing loss.

  1987cited by this paper
• Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles.

  1987cited by this paper
• Differential effect of cis-platinum (cis-diamminedichloroplatinum) on regulation of liver and kidney haem and haemoprotein metabolism. Possible involvement of gamma-glutamyl-cycle enzymes.

  1986cited by this paper
• Hypoalbuminemia in patients receiving cisplatin: correlation between liver platinum and decrease in serum albumin.

  1986cited by this paper
• A review of cis-platinum ototoxicity.

  1983cited by this paper
• Alteration of Aminoglycoside Antibiotic Ototoxicity: Effect of Semistarvation

  1983cited by this paper
• A review of cis-platinum ototoxicity.

  1983cited by this paper
• Intensified nutrition as an adjunct to cytotoxic chemotherapy in gynaecological cancer patients.

  1982cited by this paper
• Methods of reduction of cisplatin nephrotoxicity.

  1981cited by this paper
• Mechanism of cis-platinum nephrotoxicity: I. Effects of sulfhydryl groups in rat kidneys.

  1980cited by this paper
• Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

  1980cited by this paper
• Renal Function in Protein-Energy Malnutrition

  1980cited by this paper
• Renal function in protein-energy malnutrition.

  1980cited by this paper
• Evaluation of renal function in malnutrition.

  1966cited by this paper
• The influence of dietary protein intake on specific renal functions in normal man.

  1954cited by this paper
• Nitrogen exchange and caloric expenditure in patients with malignant neoplasms

  1951cited by this paper
• Analysis of Extreme Values

  1950cited by this paper
• The effect of diet on the glutathione content of the liver.

  1947cited by this paper

• Audiologic Evaluation of Patients with Head and Neck Cancers Treated with Cisplatin Based Chemotherapy: A Longitudinal Study

  2022cites this paper
• Mechanisms of Ototoxicity and Otoprotection.

  2021cites this paper
• Cisplatin-induced ototoxicity: updates on molecular mechanisms and otoprotective strategies.

  2021cites this paper
• Mechanisms of Aminoglycoside- and Cisplatin-Induced Ototoxicity

  2021cites this paper
• AJA2100006 887..900

  2021cites this paper
• Protection and repair of hearing

  2020cites this paper
• Silver(I) N-heterocyclic carbene complexes: Synthesis, characterization and cytotoxic properties

  2020cites this paper
• Use of the guinea pig in studies on the development and prevention of acquired sensorineural hearing loss, with an emphasis on noise.

  2019cites this paper
• Prospective evaluation of the early effects of radiation on the auditory system frequencies of patients with head and neck cancers and brain tumors after radiotherapy.

  2018cites this paper
• Brain Metabolic Changes in Rats following Acoustic Trauma

  2017cites this paper
• Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial

  2017cites this paper
• In Vitro Models for Ototoxic Research

  2014cites this paper
• Effect of the human serum albumin concentration on the metabolism of cisplatin in vitro

  2014cites this paper
• Ototoxicidad, otoprotección, autodefensa y regeneración del oído interno

  2014cites this paper
• Sensorineural hearing loss in patients with coronary artery bypass surgery

  2013influential citation
• Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: A retrospective evaluation

  2013cites this paper
• Effect of protein malnutrition on the metabolism and toxicity of cisplatin, 5-fluorouracil and mitomycin C in rat stomach.

  2013cites this paper
• Cisplatin-induced Ototoxicity in Pediatric Solid Tumors: The Role of Glutathione S-Transferases and Megalin Genetic Polymorphisms

  2013cites this paper
• Associations between diet and both high and low pure tone averages and transient evoked otoacoustic emissions in an older adult population-based study.

  2011cites this paper
• Разработка схемы обследования слуха у детей, получавших химиотерапию препаратами платины

  2011cites this paper
• Le rôle du lactate et du N-acétylcystéine intra-tympanique dans la prévention de l’ototoxicité secondaire au cisplatin

  2011influential citation
• Sensorineural Hearing Loss in Adults

  2010cites this paper
• Ototoxicity in patients receiving concurrent cisplatin and cranial irradiation therapy for the treatment of head and neck cancers: an audiometric follow-up

  2010cites this paper
• Oxidative stress in the cochlea: an update.

  2010cites this paper
• Ototoxic drugs: difference in sensitivity between mice and guinea pigs.

  2010cites this paper
• Endogenous protection against oxidative stress caused by cisplatin: role of superoxide dismutase

  2010cites this paper
• Ototoxic drugs : Difference in sensitivity between mice and guinea pigs

  2010cites this paper
• Effets ototoxiques du toluène et ses spécificités métaboliques (phase I et II) chez le rat et le cobaye

  2009cites this paper
• Protection and Repair of Inner Ear Sensory Cells

  2008cites this paper
• Reduced basal and lipopolysaccharide-stimulated adenosine A1 receptor expression in the brain of nuclear factor-κB p50−/− mice

  2007cites this paper
• Decreased hearing after combined modality therapy for head and neck cancer.

  2006cites this paper
• OTOTOXICIDADE, OTOPROTEÇÃO E AUTODEFESA DAS CÉLULAS CILIADAS DA CÓCLEA

  2005cites this paper
• [Aminoglycoside- and cisplatin-ototoxicity: from basic science to clinics].

  2004cites this paper
• Antioxidant protection in a new animal model of cisplatin-induced ototoxicity.

  2004cites this paper
• Aminoglykosid- und Cisplatin-Ototoxizität: von der Grundlagenforschung zur Klinik

  2004cites this paper
• Glutathione ester but not glutathione protects against cisplatin-induced ototoxicity in a rat model.

  2003cites this paper
• Sequence variations of mitochondrial DNA and individual sensitivity to the ototoxic effect of cisplatin.

  2003cites this paper
• Cisplatin induced ototoxicity : Pharmacokinetics, prediction and prevention

  2003cites this paper
• Salicylate Protects Hearing and Kidney Function from Cisplatin Toxicity without Compromising its Oncolytic Action

  2002cites this paper
• Cisplatin ototoxicity: involvement of iron and enhanced formation of superoxide anion radicals.

  2001cites this paper
• Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin

  2000cites this paper
• Ototoxicity caused by cisplatin is ameliorated by melatonin and other antioxidants

  2000cites this paper
• In vitro effects of hydrogen peroxide on the cochlear neurosensory epithelium of the guinea pig.

  2000cites this paper
• Glutathione limits noise-induced hearing loss.

  2000cites this paper
• Ototoxicity caused by aminoglycosides is ameliorated by melatonin without interfering with the antibiotic capacity of the drugs

  2000cites this paper
• Effect of violation of the labyrinth on the sensory epithelium in the chick cochlea.

  2000cites this paper
• CHAPTER 53 – PROTECTION AND REPAIR OF HEARING

  2000cites this paper
• Dose-dependent effect of 8-day cisplatin administration upon the morphology of the albino guinea pig cochlea.

  2000cites this paper
• The Role of Antioxidants in Protection from Impulse Noise

  1999cites this paper
• Ototoxic Impact of Cisplatin in Pediatric Oncology Patients

  1999cites this paper
• Aminoglycosides activate oxygen metabolites production in the cochlea of mature and developing rats.

  1999cites this paper
• Histopathology of Human Temporal Bone After Cis-Platinum, Radiation, or Both

  1998cites this paper
• Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer.

  1998cites this paper
• Reduction of cisplatin toxicity and lethality by sodium malate in mice.

  1998cites this paper
• Influence of intense sound exposure on glutathione synthesis in the cochlea.

  1998cites this paper
• Cisplatin Binding Sites on Human Albumin*

  1998cites this paper
• Free radicals and antioxidants in chemotherapy-induced toxicity.

  1997cites this paper
• Free radicals and antioxidants in chemotherapyinduced toxicity

  1997cites this paper
• Glutathione-dependent antioxidant systems in the mammalian inner ear: effects of aging, ototoxic drugs and noise.

  1997cites this paper
• Protection by 4-methylthiobenzoic acid against cisplatin-induced ototoxicity: antioxidant system.

  1997cites this paper
• A sensitive animal model to assess acute and chronic ototoxic effects.

  1996cites this paper